{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:40:07Z","timestamp":1776487207343,"version":"3.51.2"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.2169\/internalmedicine.6099-25","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T22:08:22Z","timestamp":1758146902000},"page":"1178-1181","source":"Crossref","is-referenced-by-count":0,"title":["Prosthetic Joint Infection Caused by &lt;i&gt;Streptococcus pneumoniae&lt;\/i&gt; Serotype 15F: A Rare Manifestation of an Emerging Non-vaccine Serotype"],"prefix":"10.2169","volume":"65","author":[{"given":"Masaji","family":"Saijo","sequence":"first","affiliation":[{"name":"Primary Center, Sapporo Tokushukai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadia","family":"Constantine","sequence":"additional","affiliation":[{"name":"Primary Center, Sapporo Tokushukai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Wakai","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sapporo Tokushukai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Sapporo Tokushukai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Shonan Kamakura Joint Reconstruction Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lalremruata R. Prosthetic joint infection: a microbiological review. J Med Soc 29: 120-128, 2015.","DOI":"10.4103\/0972-4958.170778"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ross JJ, Saltzman CL, Carling P, Shapiro DS. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis 36: 319-327, 2003.","DOI":"10.1086\/345954"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ispahani P, Weston VC, Turner DP, Donald FE. Septic arthritis due to <i>Streptococcus pneumoniae<\/i> in Nottingham, United Kingdom, 1985-1998. Clin Infect Dis 29: 1450-1454, 1999.","DOI":"10.1086\/313526"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of <i>Streptococcus pneumoniae<\/i> causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis. PLoS One 12: e0177113, 2017.","DOI":"10.1371\/journal.pone.0177113"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-1973, 2011.","DOI":"10.1016\/S0140-6736(10)62225-8"},{"key":"6","unstructured":"6. Lo SW, Gladstone RA, van Tonder AJ, et al.; Global Pneumococca Sequencing Consortium. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. Lancet Infect Dis 19: 759-769, 2019."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kim SH, Chung DR, Song JH, et al.; Asian Network for Surveillance of Resistant Pathogens (ANSORP). Changes in serotype distribution and antimicrobial resistance of <i>Streptococcus pneumoniae<\/i> isolates from adult patients in Asia: emergence of drug-resistant non-vaccine serotypes. Vaccine 38: 6065-6073, 2020.","DOI":"10.1016\/j.vaccine.2019.09.065"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Andrejko K, Ratnasiri B, Lewnard JA. Association of pneumococcal serotype with susceptibility to antimicrobial drugs: a systematic review and meta-analysis. Clin Infect Dis 75: 131-140, 2022.","DOI":"10.1093\/cid\/ciab852"},{"key":"9","unstructured":"9. Mathers AJ, Lewis II JS, Bryson AL, et al. M100, Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. Clinical and Laboratory Standards Institute, 2024."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet 375: 846-855, 2010.","DOI":"10.1016\/S0140-6736(09)61595-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dernoncourt A, El Samad Y, Schmidt J, et al. Case studies and literature review of pneumococcal septic arthritis in adults. Emerg Infect Dis 25: 1824-1833, 2019.","DOI":"10.3201\/eid2510.181695"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hamdad F, El Bayeh N, Auger G, et al. Pneumococcal septic arthritis among adults, France, 2010-2018. Emerg Infect Dis 31: 8-17, 2025.","DOI":"10.3201\/eid3101.240321"},{"key":"13","unstructured":"13. Centers for Disease Control and Prevention. Pneumococcal vaccination: Recommendations [Internet]. [cited 2025 May]. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/who-when-to-vaccinate.html"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ubukata K, Takata M, Morozumi M, et al. Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010-2017. Emerg Infect Dis 24: 2010-2020, 2018.","DOI":"10.3201\/eid2411.180326"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van der Linden M, Perniciaro S, Im\u00f6hl M. Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era. BMC Infect Dis 15: 207, 2015.","DOI":"10.1186\/s12879-015-0941-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011. Emerg Infect Dis 19: 1074-1083, 2013.","DOI":"10.3201\/eid1907.121830"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shi W, Du Q, Yuan L, Gao W, Wang Q, Yao K. Antibiotic resistance and molecular biological characteristics of non-13-valent-pneumococcal conjugate vaccine serogroup 15 <i>Streptococcus pneumoniae<\/i> isolated from children in China. Front Microbiol 12: 778985, 2022.","DOI":"10.3389\/fmicb.2021.778985"},{"key":"18","unstructured":"18. Okuya M, Imtaka G, Takagi Y, et al. Sepsis caused by <i>Streptococcus pneumoniae<\/i> in an infant who had received a history of pneumococcal vaccination: report of three infant cases. Dokkyo J Med Sci 51: 48-54, 2024 (in Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Browall S, Backhaus E, Naucler P, et al. Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types. Eur Respir J 44: 1646-1657, 2014.","DOI":"10.1183\/09031936.00080814"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Alanee SR, McGee L, Jackson D, et al.; International Pneumococcal Study Group. Association of serotypes of <i>Streptococcus pneumoniae<\/i> with disease severity and outcome in adults: an international study. Clin Infect Dis 45: 46-51, 2007.","DOI":"10.1086\/518538"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine 32: 2399-2405, 2014.","DOI":"10.1016\/j.vaccine.2014.02.096"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Siira L, Vestrheim DF, Winje BA, Caugant DA, Steens A. Antimicrobial susceptibility and clonality of <i>Streptococcus pneumoniae<\/i> isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016. Vaccine 38: 5454-5463, 2020.","DOI":"10.1016\/j.vaccine.2020.06.040"},{"key":"23","unstructured":"23. Cabinet Office Japan. Annual Report on the Ageing Society [Summary] FY2023 [Internet]. [cited 2024 May]. Available from: https:\/\/www8.cao.go.jp\/kourei\/english\/annualreport\/2023\/pdf\/2023.pdf"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_6099-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:51:22Z","timestamp":1776484282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/8\/65_6099-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6099-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"6099-25"}}